Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Clinical trial NCT04120636 · UNKNOWN

Trial details

NCT number: NCT04120636
Sponsor: Targeted Therapy Technologies, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Macula Edema Radiation Retinopathy Branch Retinal Vein Occlusion Epiretinal Membrane Central Serous Retinopathy With Pit of Optic Disc Commotio Retinae Vitritis

Start date: 2021-03-05
Primary completion: 2024-06-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.